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Abstract: Peroxisomal biogenesis and function critically depends on the import of cytosolic 
proteins carrying a PTS1 sequence into this organelle upon interaction with the peroxin 
Pex5p. Recent structural studies have provided important insights into the molecular 
recognition of cargo proteins by Pex5p. Peroxisomal import is a key feature in the pathogenesis 
of primary hyperoxaluria type 1 (PH1), where alanine:glyoxylate aminotransferase (AGT) 
undergoes mitochondrial mistargeting in about a third of patients. Here, we study the 
molecular recognition of PTS1 cargo proteins by Pex5p using oligopeptides and AGT 
variants bearing different natural PTS1 sequences, and employing an array of biophysical, 
computational and cell biology techniques. Changes in affinity for Pex5p (spanning over  
3–4 orders of magnitude) reflect different thermodynamic signatures, but overall bury 
similar amounts of molecular surface. Structure/energetic analyses provide information on 
the contribution of ancillary regions and the conformational changes induced in Pex5p and 
the PTS1 cargo upon complex formation. Pex5p stability in vitro is enhanced upon cargo 
binding according to their binding affinities. Moreover, we provide evidence that the  
rational modulation of the AGT: Pex5p binding affinity might be useful tools to investigate 
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mistargeting and misfolding in PH1 by pulling the folding equilibria towards the native and 
peroxisomal import competent state. 
Keywords: peroxisomes; protein import; primary hyperoxaluria type I; peroxin 5; 
protein:protein interactions; binding energetics; structure-energetic correlations 
 
1. Introduction 
Peroxisomes are highly specialized organelles ubiquitously found in eukaryotic cells and involved in 
specific metabolic processes, such as fatty acid  β-oxidation and glyoxylate detoxification [1,2].  
Proper peroxisomal biogenesis relies on the import of proteins synthesized in the cytosol by two 
peroxisomal targeting sequence (PTS) pathways [3]. The PTS type 1 (PTS1) pathway is the most widely 
used, and depends on the interaction of the peroxin 5 (Pex5p) receptor with a C-terminal peptide with  
a (S/A/C)-(K/R/H)-(L/M) consensus sequence [1]. The PTS type 2 (PTS2) pathway uses a degenerated 
N-terminal nonapeptide that is cleaved upon import, and seems to interact with a Pex5p/Pex7p complex 
in mammals [3]. The structural basis of the recognition of PTS1 cargo proteins has been the focus of  
a few remarkable studies, which have shown that the interaction of different cargo proteins with Pex5p 
may involve different structural mechanisms [4–6], and therefore the thermodynamic fingerprint for this 
recognition may diverge among cargo proteins. Indeed, differences in the molecular recognition patterns 
and therefore the affinity of Pex5p for their cargo proteins may correlate with their expression levels, 
thus allowing the existence of a pool of Pex5p-cargo protein complex levels compatible with proper 
peroxisomal biogenesis [7]. However, detailed structure/energetic analyses for the molecular recognition 
of cargo proteins by Pex5p is lacking. 
Human alanine: glyoxylate aminotransferase (AGT) is a PLP-dependent enzyme that catalyzes the 
conversion of alanine to pyruvate and glyoxylate to glycine in hepatocytes, and its main role is the 
detoxification of glyoxylate in peroxisomes, which is its normal localization in humans [2,8,9]. Genetic 
mutations in the AGXT gene impairing AGT function are the cause of primary hyperoxaluria type I 
(PH1), a rare genetic disease inherited in an autosomal recessive manner [2,9,10]. Mutations often 
decrease the ability of AGT to fold into active dimers and in some cases also lead to mitochondrial 
mistargeting of the enzyme [11–13]. Misfolding and mistargeting in PH1 seems to be primarily caused 
by protein stability problems [9,12,14], which can be overcome by supplementation with vitamin B6 
thus boosting intracellular levels of PLP and AGT stability [12,15]. The presence of two polymorphisms 
(p.P11L and p.I340M) that constitute the minor allele predispose the AGT enzyme towards deleterious 
mutations by reducing AGT intracellular foldability, establishing a folding and stability threshold 
separating health and disease [16]. The most common mutation in the minor haplotype, p.G170R 
(p.P11L/p.G170R/p.I340M), named AGT-LRM for short, is also the best characterized mistargeting 
AGT variant. Remarkably, the fate of a given PH1 causing variant (e.g., misfolding/aggregation in 
peroxisomes vs. mitochondrial mistargeting) depends on the expression conditions used [11–13], thus 
suggesting that the complex kinetic and thermodynamic relationships altered by the mutation and 
controlling AGT folding, misfolding and mistargeting inside cells can be modulated to a certain extent, 
and thus, could be exploited to provide new pharmacological treatments for this disease. 
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In the present study, we investigate the thermodynamic and structural basis of the molecular recognition 
of cargo proteins by Pex5p employing different natural PTS1 sequences with widely different affinities, 
using peptides and the corresponding sequences introduced at the PTS1 sequence of the human AGT. 
We hypothesize that the subcellular localization of human AGT variants is the result of a balance 
between interactions of the folded AGT dimer with the peroxisomal import machinery and binding of a 
partly folded AGT to cellular chaperones that facilitate mitochondrial import. Thus, we have analyzed 
Pex5p binding to the wild-type AGT protein and the mistargeting AGT (AGT-LRM) displaying different 
C-terminal PTS1 sequences. Our results suggest that beyond the specific interactions of Pex5p with the 
PTS1 sequence, additional ancillary regions in the cargo protein as well as conformational and dynamic 
changes in both cargo and receptor proteins may contribute significantly to the binding affinity and 
therefore display different thermodynamic signatures. Moreover, these designed AGT variants can be 
used to tune the intracellular misfolding and mistargeting of PH1-causing variants, and may be useful 
tools to get further insight into the molecular mechanisms underlying PH1. 
2. Results and Discussion 
2.1. Modeling the Interaction of AGT and Pex5p-pbd 
The interaction between AGT and the PTS1 binding domain of Pex5p (Pex5p-pbd) exclusively 
involves the C-terminal domain of AGT (residues 283–392) (PDB: 3R9A; Figure 1A). While the overall 
conformation and activity of AGT are not significantly affected by the interaction, a conformational 
change is observed in the C-terminal bundle domain of Pex5p-pbd [5]. The reported structure shows 
three topologically distinct regions of AGT interacting in the complex (Figure 1A): (i) residues 389–392, 
which constitute the minimal PTS1 sequence and interact with the central cavity of the TPR domains of 
Pex5p-pbd. This region forms an interface with the receptor of about 600 Å2 [5]; (ii) residues 381–388 
(helix α13) and 327–330 (contained in the ancillary targeting sequence or PTS1A; [17]), and recently 
named the extended PTS1 [5]. Mutation of residues in this region show mild to moderate changes in 
affinity (about 2-fold lower affinity in Y330W and A328W, and about 5-fold in Y330A; [5]); (iii) 
residues 303–307. Regions II and III form an additional surface of about 400 Å2 [5]. Changes in 
molecular surface upon complex formation at the residue level are shown in Figure 1B,C. 
Previous work with model peptides has shown that the recognition of PTS1 peptides by Pex5p-pbd 
resides to a large extent in the C-terminal tripeptide (positions 1 to 3; [18]), even though residues upstream 
of this tripeptide may also contribute to the binding affinity by at least two orders of magnitude [19]. 
However, these studies focused on the binding affinity (i.e., binding free energy, ΔG, which is related to 
the association constant Ka by ΔG = R·T·lnKa), and did not investigate the possible effect on the 
enthalpic (ΔH) and entropic (TΔS) contributions (ΔG = ΔH  TΔS), which may suggest a link between 
changes in binding affinity with structural and dynamic differences in the complexes [20–22]. Very 
recently, Fodor et al. [6] characterized the impact of specific residues of the human AGT PTS1 
octapeptide sequence on the affinity for Pex5p-pbd by alanine scanning mutagenesis and isothermal 
titration calorimetry using full-length human AGT. Mutations at residues Q385, P388 and K389 
(positions 8, 5 and 4 in AGT, respectively) had little effect on binding affinity (lower than 2-fold). 
Interestingly, the K389A mutant showed only 1.8-fold lower affinity but reduced the enthalpic 
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penalization to binding by 10 kJ/mol. These findings are difficult to be solely explained by changes in 
molecular buried surface and alternatively may reflect significant structural reorganization in the complex 
and large enthalpy/entropy compensations. Mutations at the 3 and 2 positions have a much larger 
effect on binding affinity. The K390A back-to-consensus mutation (-KKL to -AKL) increases the binding 
affinity for the Pex5p-pbd receptor, and this effect is mainly explained by a 4 kJ/mol decrease in the 
enthalpic penalization, likely due to the shrinkage of the binding site and optimization of short-range 
interactions reported by X-ray crystallography [6]. Conversely, the K391A variant (that forms the very 
weak -KAL tripeptide) showed no detectable binding, which is in turn compensated in the double mutant 
K390A/K391A apparently due to structural optimization of specific interactions in the binding sites 
(further supported by the decrease in enthalpic penalization of 6 kJ/mol). The results from this elegant 
study suggest that the recognition of PTS1 cargo proteins by Pex5p is highly plastic from both structural 
and energetic viewpoints. 
 
 
Figure 1. (A) Molecular architecture of the AGT:Pex5-pbd complex (PDB code: 3R9A), 
indicating the three regions in AGT involved in the interaction surface. The amount of polar 
and apolar surface buried is determined from this complex and used to estimate theoretical 
values of intrinsic enthalpy and heat capacity of binding using Equations (1) and (2) (B)  
and (C) Changes in accessible surface at the residue level for AGT (B) and Pex5p-pbd (C) 
upon complex formation. 
The availability of crystal structures for AGT: Pex5p-pbd complexes allow the estimation of some 
thermodynamic theoretical values corresponding to the intrinsic binding process (excluding conformational 
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changes and ionization effects coupled to binding). Upon complex formation, total changes in polar and 
apolar surface  (ΔASApolar and ΔASAapolar) are 855 Å2 and 1176 Å2 (Figure 1A), therefore yielding 
theoretical values for the intrinsic  ΔCp and ΔH values upon binding of 1.29 kJ/(mol·K) and 74.9 kJ/mol 
based on Equations (1) and (2) (see also [20]). These analyses set reference values to be contrasted with 
the calorimetric analyses performed in the present work, and to infer thermodynamic properties due to 
conformational changes. In the case that we use the complex AGT-WT-Pex5p-pbd to model different 
PTS1 sequences (Table 1 and Figure 2), we will obviously obtain a constant contribution from region III, 
and likely a variable contribution from regions I and II in the AGT (Figures 1A and 2). Similarly, 
conformational changes in the C-terminal bundle of Pex5p-pbd are expected to remain constant across 
different modeled PTS1 sequences unless binding of AGT variants causes different long-range effects, 
while some differences in the TPR cavity are expected. To determine these intrinsic theoretical values 
for the different PTS1, we have modeled them using the available crystal structures, and the calculations 
of  ΔASApolar and  ΔASAapolar for the different PTS1 were carried out using the entire AGT protein and 
also for the 385–392 C-terminal octapeptide (compiled in Table 2). It must be noted that the overall 
conformations of the three AGT-Pex5p-pbd crystallographic complexes available are very similar, and 
they mainly differ in the adaptation of Pex5p-pbd cavity to accommodate the reduced size of the mutated 
residues at positions 3 and 2 [5,6]. Thus, it is likely that the analyses of the pattern of interactions 
between AGT and Pex5p-pbd (Figure 2B) can be used to explain our subsequent calorimetric analyses 
on the five AGT mutated versions to some extent. The C-terminal residues of AGT protrude into a central 
cavity of Pex5p-pbd forming both hydrogen bonds and hydrophobic interactions. Of them, residues 
K390, K391 and L392 are partially buried in a Pex5p-pbd central cavity while residues from Q385 to 
K389 are placed at the interface between AGT and the receptor. This suggests that mutations in the far 
C-terminal residues affect the structure of the receptor, while mutations in the rest of the tail may alter 
the relative position of the receptor with respect to AGT. To provide insights to this idea, we modeled 
the sequence of the five mutant proteins using as a template the structure of the AGT-Pex5p-pbd K390A 
mutant complex. Our models show that most mutations could be accommodated in the complex with 
minimal modifications of the original structure as none of them is totally buried in the complex interface. 
Conversely, the large and hydrophobic Leu side chain at 388 would require a structural reorganization 
(Figure 2B). 
Table 1. PTS1 octapeptide sequences studied in this work. The protein sequence in which 
these octapeptides are naturally found, as well as their previously determined dissociation 
constant, are indicated [7]. In red, we indicate the variations in sequence found when the 
peptides are compared with the PTS-1 sequence of human AGT. N.Det.: not determined. 
PTS1 Sequence Enzyme Sequence Kd (nM) 
AGT AGT QHCPKKKL 13490 
AGT-SKL AGT + consensus tripeptide QHCPKSKL N.Det. 
BFE L-Bifunctional enzyme AGSPSSKL 1096 
HMG 3-Hydroxy-3-methylglutaryl-CoA lyase VAQATCKL 1995 
CRA Carnitine acyl-transferase 1 QSHPRAKL 59 
ACO Acyl-CoA oxidase 3 VGSLKSKL 1.6 
Biomolecules 2015, 5 126 
 
 
 
Figure 2. (A) Structural details of the interaction between AGT and Pex5p-pbd (PDB: 3R9A) 
(B) Overview of the modeled structures of AGT with modified PTS1 sequences. 
Table 2. Changes in accessible surface (ΔASA) predicted for the AGT-Pex5p-pbd complexes 
studied here. Data correspond to the full length AGT with different PTS1 sequences. 
PTS1 Sequence 
ΔASA (for AGT) (Å2) ΔASA (for Peptide) (Å2) 
Apolar Polar Apolar Polar 
AGT 1176 855 802 579 
AGT-SKL 1075 812 718 599 
BFE 1069 659 673 450 
HMG 1100 703 715 493 
CRA 1126 776 731 580 
ACO 1168 713 783 519 
2.2. PTS1 Sequence Dependence of the Interaction between AGT and Pex5p-pbd:  
Enthalpy-Entropy Compensations 
Binding of AGT to Pex5p-pbd show a stoichiometry of 1:1 (Figure 3 and Table 3, see also [5,12]). 
Interestingly, the wild-type (AGT) and disease-causing AGT-LRM mutant show virtually identical affinities 
as well as thermodynamic signatures (Table 3). Introduction of the consensus -SKL tripeptide into either 
AGT or AGT-LRM variants produces a 50-fold increase in the affinity for the receptor, as well as a 
decrease in the enthalpic penalty of 16 kJ/mol. A similar behavior has been recently described for the -AKL 
tripeptide (mutation K390A of AGT; [6]), and accordingly, may also reflect an optimization of the 
interactions between the PTS1 sequence of AGT and the Pex5-pbd in the consensus -SKL PTS1 sequence. 
A B 
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Figure 3. ITC binding analysis of AGT-LRM and AGT-LRM-SKL proteins with Pex5p-pbd. 
Thermograms (A) and binding isotherms (B) at 25 °C for AGT-LRM, AGT-LRM-HMG and 
AGT-LRM-SKL; AGT-LRM (15 M in subunit) was titrated using Pex5p-pbd 350 M  
(29 injections of 1.2 L) while AGT-LRM-HMG and AGT-LRM-SKL (20 M in subunit) 
was titrated using Pex5p-pbd 250 M (12–16 injections of 2–2.2 L). 
Table 3. Thermodynamic binding parameters for the interaction of Pex5p-pbd with AGT 
and AGT-LRM variants at pH 7.4 and 25 °C. Data are mean ± s.d. of three independent titrations. 
AGT Variant N Kd ΔG (kJ/mol) H (kJ/mol) -TS (kJ/mol) ΔCpa (kJ/molK) 
AGT 1.0 ± 0.1 1.4 ± 0.2 μM 33.5 ± 0.4 21.7 ± 3.7 55.2 ± 1.2 2.5 ± 0.4
AGT-LRM 1.1 ± 0.1 1.6 ± 0.4 μM 33.0 ± 0.8 21.3 ± 0.4 55.3 ± 3.6 2.7 ± 0.2
AGT-SKL 0.8 ± 0.1 44 ± 10 nM 43.1 ± 0.9 6.3 ± 0.8 49.4 ± 1.7 2.7 ± 0.1
AGT-LRM-SKL 0.9 ± 0.1 65 ± 27 nM 41.0 ± 0.7 5.0 ± 0.3 46.0 ± 0.5 2.6 ± 0.1 
a ΔCp values are determined from the linear dependence of H on temperature. 
As noted above, residues upstream from the C-terminal tripeptide of the PTS1 sequence may strongly 
modulate binding affinity [18,19]. Therefore, we have introduced PTS1 octapeptides previously described 
by [7] and displaying widely different binding affinities for Pex5p-pbd (Table 1). As expected from this 
previous report, we observed an increase in binding affinity compared to the natural PTS1 sequence of 
AGT (Figure 4A and Table 4). On the AGT-LRM background, several PTS1 sequences (AGT-SKL, 
CRA and HMG, Table 1) increased the affinity with a significant reduction of the enthalpic penalties 
(about 16 kJ/mol), while the BFE sequence (showing only a 2-fold increase in affinity) shows much 
favorable enthalpic contribution (about 35 kJ/mol) and much less favorable entropic contribution to 
binding (Figure 4A). These changes in the enthalpic contributions to binding could be at least partly 
explained by structural optimization of the PTS1 sequence at the Pex5p-pbd binding site similar to that 
proposed for the AGT–SKL variant (Table 3) and found for the K390A AGT mutant [6]. We must also 
note that the changes in binding affinity found are relatively modest in most of the cases due to significant 
enthalpy/entropy compensations (Figure 4A and [6]), highlighting the complex sequence/energetic 
dependence of the molecular recognition of PTS1 cargo proteins by Pex5p-pbd, which goes beyond the 
–SKL consensus tripeptide. 
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Figure 4. Thermodynamic binding properties for the interaction of protein variants on the 
AGT-LRM background with Pex5p-pbd. (A) Free energy (ΔG), enthalpy (ΔH) and entropy 
(TΔS) contributions to the binding reaction; (B,C) Thermodynamic dissection of binding 
enthalpies (B) and heat capacity changes (ΔCp, C) into their intrinsic contribution (estimated 
from polar and apolar ΔASA using the crystal structure for the complex; Figure 1) and the 
contribution from conformational changes. In (A,B), data are mean ± s.d. for three independent 
experiments at 25 °C. 
Table 4. Thermodynamic binding parameters for the interaction of PTS1 peptides and  
AGT-LRM variants with Pex5p-pbd at pH 7.4 and 25 °C determined by ITC. N.Det.  
not determined. 
AGT a Kd Peptide b Kd 
AGT-LRM 1.6 ± 0.4 μM pAGT 19  μM 
AGT-LRM-SKL 65 ± 27 nM pAGT-SKL 29 nM 
AGT-LRM-CRA 40 ± 25 nM pCRA 157 nM 
AGT-LRM-BFE 0.74 ± 0.25 μM pBFE 145 nM 
AGT-LRM-HMG 0.28 ± 0.04 μM pHMG N.Det. 
AGT-LRM-ACO N.Det. pACO 14 nM 
a Data are mean ± s.d. of three independent titrations; b Data are means of two independent titrations. 
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The experimental enthalpic contributions to binding may be structurally rationalized using well-known 
structure/energetic relationships [20]. Since the binding enthalpies are not dependent on the chosen 
buffer (giving similar values in HEPES and phosphate; data not shown [23]), contributions from 
ionization events upon binding should be ruled out. Therefore, the experimental binding enthalpies can 
be dissected in two main terms: (i)  ΔHint, arising from the surface area (polar and apolar) buried upon 
binding; this term can be calculated from the crystal structures (Figure 1) and models provided in this 
work (Figure 2 and Table 2); (ii)  ΔHconf, which arises from conformational changes in the cargo protein 
and Pex5p-pbd receptor upon binding. This term is evaluated from the difference between the experimental 
and intrinsic binding enthalpies. We must note that this energetic dissection is aimed to detect large 
differences between experimental and structure-derived theoretical values, thus allowing propose the 
existence of different conformational changes upon cargo binding, but not provide a detailed structural-
energetic description of complex formation that could be a difficult task even if high-resolution crystal 
structures would be available for the complexes. These two terms (ΔHint and ΔHconf) have been estimated 
for the five variants on the AGT-LRM background experimentally studied (Figure 4B).  ΔHint seems to 
moderately vary among these five variants, from 57 kJ/mol to 75 kJ/mol (mean ± s.d. = 65 ± 10 kJ/mol), 
being always favorable to binding. However, ΔHconf largely varies among these AGT proteins, with 
values ranging from 35 to 96 kJ/mol (mean ± s.d. = 69 ± 22 kJ/mol), and is thus always unfavorable to 
binding. We must finally note that the contributions from  ΔHconf and ΔHint show little or no correlation 
with the binding affinity, supporting complex enthalpy/entropy compensations ultimately leading to the 
given binding affinity for Pex5p-pbd-AGT complex formation. 
A similar dissection has been performed for the binding heat capacities, for which the experimental 
values are virtually identical for the five AGT-LRM variants studied (Figure 4C). In this case, both 
contributions are of the same sign and contribute similarly to the experimental value (mean ± s.d.  
of 1.26 ± 0.07 and 1.40 ± 0.08 kJ/mol, for the intrinsic and conformational components, respectively), 
and thus, very small changes in each contribution among the AGT proteins studied. This likely reflects 
the different contributions of polar and apolar surface burial to the binding enthalpies and heat capacities 
(see Equations (1) and (2)). 
2.3. Interaction between PTS1 Nonapeptides and Pex5p-pbd Provide Insight into the Contribution 
from Ancillary Regions to Binding Energetics 
Representative ITC binding analyses of nonapeptides (containing PTS1 octapeptides plus a N-terminal 
tyrosine residue) to Pex5p-pbd are shown in Figure 5. A comparison of the binding affinities of these 
PTS1 nonapeptides with their corresponding full-length AGT counterparts reveals about one order of 
magnitude lower affinity for the peptides (Table 4; with the exception of AGT-SKL, that is close to the 
detection limit of ITC for a direct titration), in reasonable agreement with previous reports for AGT and 
SCP2 proteins [5–7]. The lower affinity in the peptides likely reflects the contributions from ancillary 
regions in the full-length cargo protein to complex formation, even though other minor contributions 
(such as electrostatic effects due to the presence of a charged N-terminal amine group in the peptides) 
should not be ruled out. Nevertheless, the difference in affinity between AGT proteins and PTS1 
nonapeptides shows a reasonable correlation in terms of binding enthalpies and entropies (Figure 6A), 
suggesting the conservation of this context dependent cargo recognition (full-length protein vs. peptide) 
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to some extent. This supports the idea that, overall, the binding mode of all AGT proteins to Pex5p-pbd 
is similar and mainly encoded in the C-terminal octapeptide sequence, while other ancillary regions in 
the AGT protein roughly add one order of magnitude to the binding affinity. 
 
Figure 5. ITC analysis of the binding of the peptides pAGT and pAGT-SKL to Pex5p-pbd. 
Thermograms (A) and binding isotherms (B) at 25 °C for pAGT (squares) and pAGT-SKL 
(circles); Pex5p 20 M was titrated using 0.5 mM of pAGT and pAGT-SKL peptides  
(25–30 injections of 1.2–1.5 L). 
A comparative analyses of the intrinsic and conformational contributions to the experimental ΔH and 
ΔCp value may provide some insight into this gain in affinity between full-length cargo protein and the 
nonapeptides (Figures 6 and 7). In general, the peptides show a lower enthalpic penalization to binding, 
which indicates that a significant fraction of this penalization in the full-length protein arises from 
ancillary regions, and is somewhat entropically compensated. While the contributions to the enthalpy show 
similar nature in the full-length AGT and the peptides, the average favorable contribution from the 
intrinsic component is 17 kJ/mol lower in the peptide, while the conformational component reduces its 
penalization by about 33 kJ/mol, thus supporting the notion that the ancillary regions contribute 
favorably in terms of solvent exposure but unfavorably in terms of conformational changes (which is the 
main source of the enthalpic penalization to binding in the full-length AGT). As found for full-length 
proteins, the correlation between intrinsic and conformational components to the binding affinity is weak 
(Figure 6B). In the case of binding heat capacities, the behavior of the peptides is similar to that of the 
full-length protein, but as expected, the contribution of the intrinsic component is lower due to the 
smaller changes in solvent accessibility compared to the full-length protein. 
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Figure 6. Context dependence of binding thermodynamics to Pex5p-pbd. (A) correlation  
of binding thermodynamic parameters between AGT proteins and PTS1 nonapeptides;  
(B) Binding free energies show little or no correlation with the different contributions 
(conformational or intrinsic) to binding enthalpies. In panel b, closed symbols are for AGT 
proteins and open symbols for PTS1 nonapeptides. 
 
 
 
Figure 7. Thermodynamic binding properties for the interaction of PTS1 nonapeptides with 
Pex5p-pbd. (A) Free energy (ΔG), enthalpy (ΔH) and entropy (TΔS) contributions to the 
binding reaction; (B,C) Thermodynamic dissection of binding enthalpies (B) and heat capacity 
changes (ΔCp, C) into their intrinsic contribution (estimated from polar and apolar ΔASA 
using the crystal structure for the complex; Figure 1) and the contribution from conformational 
changes. In (A,B), data are means for two independent experiments at 25. 
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2.4. In Vitro Stabilization of Pex5-pbd Upon Peptide Binding Correlate with Binding Affinity 
Protein-protein interactions may lead to intracellular stabilization of the protein partners, and 
alterations in binding and subsequent stabilization may contribute to human disease [24,25]. Stabilization 
(at least in vitro) is often interpreted as the preferential binding of the partners as folded conformations 
rather than as non-native conformations, and in principle, the degree of stabilization may be related to 
binding affinity. We have thus tested whether binding of PTS1 sequences may stabilize Pex5p-pbd  
using our set of peptides, instead of AGT proteins because the latter show extremely high thermal and 
kinetic stabilities in vitro [12,26]. To this end, we have used two complementary approaches: thermal 
denaturation experiments monitored by circular dichroism (Figure 8), and proteolysis kinetics under 
native conditions (Figure 9). 
 
Figure 8. Thermal stabilization of Pex5p-pbd upon PTS1 nonapeptide binding. (A–E) show 
thermal denaturation profiles in the absence or presence of different peptide concentrations 
(as the colors indicated); (F) shows the thermal up-shift (ΔTm) of Pex5p-pbd as a function  
of peptide concentration. 
Thermal denaturation of Pex5p-pbd is irreversible and kinetically controlled (data not shown [23]), 
yielding a single denaturation transition with a Tm of ∼51 °C (Figure 8). Addition of increasing concentrations 
of PTS1 nonapeptides leads to a gradual stabilization of Pex5p-pbd (Figure 8A–E). Interestingly, the 
peptide concentration dependence of thermal stabilization correlates well with their corresponding 
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binding affinities (Figure 8F), which is compatible with a scenario in which the Pex5p-pbd peptide 
complex is kinetically protected against thermal denaturation, and thus, that the amount of free Pex5p-pbd 
protein determines to a large extent the rate of protein denaturation. Therefore, we hypothesize that cargo 
binding to Pex5-pbd may stabilize both the receptor and the cargo protein intracellularly, and this 
stabilization is plausibly linked to the binding affinity and the levels of Pex5p-pbd and cargo proteins. 
Proteolysis is a useful tool to examine the effect of ligand binding on protein stability and  
dynamics [27–29]. We have thus examined changes in Pex5-pbd dynamics upon peptide binding by 
determining the proteolysis kinetic pattern in the presence of thermolysin (Figure 9). Pex5p-pbd is very 
sensitive to proteolytic attack by thermolysin, and displays a half-life of about 8 min in the presence of 
a 1:2000 protease:protein ratio. Addition of PTS1 nonapeptides protect towards proteolysis without 
changing the partial proteolysis pattern (Figure 9A), from a mild 1.5-fold with p.AGT and p.BFE to a 5-fold 
in p.CRA (Figure 9B). This protective effect is concentration-dependent (Figure 9C) and correlates  
fairly well with their corresponding affinities, as also observed for thermal denaturation of Pex5-pbd. 
This suggests that proteolysis kinetics are reflecting peptide binding effects on Pex5p-pbd dynamics 
and/or conformational stability. 
 
Figure 9. Proteolysis of Pex5p-pbd in the absence and presence of PTS1 nonapeptides.  
(A) SDS-PAGE gels of proteolysis kinetics of Pex5p-pbd in the absence or presence of 
peptides. MW indicates molecular weight markers in kDa, and the native band of Pex5p-pbd 
is indicated by a red arrow. Gels were stained with Coomassie blue brilliant; (B) Proteolysis 
kinetics of the native band of Pex5p-pbd. Lines are best-fits to a single exponential function; 
(C) Fraction of native Pex5p-pbd after 32 min proteolysis in the absence (horizontal dashed 
red line) and presence of different peptide concentrations. Thermolysin and Pex5p-pbd 
concentrations were 10 nM and 20  μM, respectively. In (A) and (B) peptide concentration 
was 500  μM. 
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2.5. Partial Correction of the Mistargeting Phenotype in a Disease-Causing AGT Variant by 
Enhancing PTS1 Binding Affinity 
Folding, misfolding and mistargeting of human AGT inside cells is a remarkably complex process [12]. 
Wild-type AGT is known to transiently interact with molecular chaperones (Hsp70 and Hsp90) on  
its way to reach the functional and peroxisomal competent dimeric state [26]. However, upon synthesis, 
PH1 disease-causing variants are known to interact more strongly with Hsp70, Hsp90 and Hsp60 
chaperones [12,13,26,30], and this behavior is either observed for variants classically associated to 
mitochondrial mistargeting or to peroxisomal aggregation. Similarly, PH1 variants associated to mistargeting 
or aggregation are often thermally and kinetically unstable, especially in their apo-form [12,26]. In some 
cases, aggregation has also been linked to altered conformational dynamics of the N-terminal of human 
AGT [31]. On the basis of all these results, we have recently proposed that several steps of the intracellular 
folding and assembly of human AGT would be affected in PH1 variants, and thus, may be potentially 
targeted for pharmacological treatment of PH1. We must note that it is possible that mitochondrial 
mistargeting and/or misfolding leading aggregation may kinetically trap the human AGT protein along 
its folding/misfolding/mistargeting processes, and therefore simply targeting steps from an equilibrium 
perspective (for instance, using native-state ligands) may not be efficient as new therapeutic approaches. 
Nevertheless, the fact that a given PH1 variant may lead to either mitochondrial mistargeting or enhanced 
aggregation depending on the expression conditions in eukaryotic cells [11,12] suggests that human 
AGT is not kinetically trapped along its folding/misfolding/mistargeting pathways and its final fate  
is amenable to modulation by environmental conditions (temperature, the presence of osmolytes, ligands, 
and so on). 
We have thus studied whether an increase in binding affinity of the human AGT native state for Pex5p 
could shift the equilibrium of human AGT along is folding/mistargeting pathways inside cells. To do so, 
we transiently transfected CHO cells with plasmids expressing the AGT-LRM variant, which is classically 
associated with mitochondrial mistargeting, and this variant with the PTS1 sequence mutated to the high 
affinity consensus –SKL C-terminal tripeptide (AGT-LRM-SKL). Confocal immunofluorescence images 
of a total of 443 cells were analyzed for the expression of AGT-LRM and AGT-LRM-SKL proteins and 
its colocalization with either mitochondria or peroxisomal markers is given in Table 5. As we show in 
Figure 10, the AGT-LRM variant is mostly found in mitochondria (Rr = 0.90, with 92% colocalization). 
However, in AGT-LRM-SKL, we observe a significant fraction of the protein in peroxisomes (84%), 
with a significant decrease in the colocalization with mitotracker in the mitochondria (Rr = 0.47, with 
40% colocalization). The 95% confidence intervals for the percentage of mitochondrial localization in 
the two tested situations are disparate: in AGT-LRM 0.66 < m¯ < 1.16 vs. AGT-LRM-SKL: 0.24 < m¯ < 0.56. 
Similarly, the amount of AGT-LRM localized in peroxisomes (17%) appears significantly lower than 
AGT-LRM-SKL (84%). Both colocalization parameters correlate well with their respective Pearson’s 
coefficients: 0.39 in the AGT-LRM vs. 0.79 in AGT-LRM-SKL. The 95% confidence intervals are 
disparate in this case too: 0.15 < m¯ < 0.44 vs. 0.68 < m¯ < 1. However, the standard error for the study of 
AGT-LRM colocalization with peroxisomal marker PMP70 is relatively high, making the confidence 
interval wide. 
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Table 5. Descriptive statistics of intensity correlation coefficient-based (ICCB) parameters 
in CHO cells. Mean Pearson’s correlation coefficient ( r¯  ) and the mean Manders’ percentage 
of colocalization (m¯ ) were determined as described previously [32], in the 4 experimental 
situations for: 1. AGT-LRM transfected cells in mitochondria; 2. AGT-LRM transfected cells 
in peroxisomes; 3. AGT-LRM-SKL transfected cells in mitochondria and 4. AGT-LRM-SKL 
transfected cells in peroxisomes. Abbreviations: AGT = alanine: glyoxylate aminotransferase, 
Mt = mitochondria, Px = peroxisomes. As a % of colocalization, we used Manders’ overlap 
R in situations 1 and 4, and split Manders’ M1 in situations 2 and 3. 
 Experimental situations 
ICCB 
Parameters 
1. AGT-LRM  
Mt: AGT + Mitotracker 
2 AGT-LRM  
Px:AGT + PMP70 
3. AGT-SKL  
Mt:AGT + mitotracker 
4. AGT-SKL  
Px:AGT + PMP70 
Pearson Rr % Coloc Pearson Rr % Coloc Pearson Rr % Coloc Pearson Rr % Coloc 
# cells 75 50 169 149 
r/m ± S.E. 0.90 ± 0.12 0.92 ± 0.12 0.39 ± 0.15 0.17 ± 0.15 0.47 ± 0.08 0.40 ± 0.08 0.79 ± 0.08 0.84 ± 0.08 
 
 
Figure 10. The consensus AGT-SKL sequence partially corrects mitochondrial mistargeting 
of AGT-LRM. Immunolocalization of AGT-LRM and AGT-LRM-SKL with mitochondrial 
(mitotracker) and peroxisomal (PMP-70) markers. 
This interpretation is also coherent with recent findings [33] that blocking mitochondrial import 
machinery partly resolves the mistargeting of AGT-LRM. Thus, the final localization of AGT-LRM 
Anti-AGT MitoTracker Merge 
AGT-LRM 
AGT-LRM-
SKL 
Merge 
Anti-AGT Anti-PMP70 Merge 
AGT-LRM 
AGT-LRM-
SKL 
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seems to depend on the balance between the opposing forces of mitochondrial and peroxisomal import 
machineries, mediated by interactions with cellular chaperones and Pex5p, respectively. 
3. Experimental Section 
3.1. Peptides and Proteins 
The peptides were synthesized by EZ Biolabs (Carmel, IN, USA) at >95% purity. The octapeptide 
sequences correspond to the C-terminal sequences of human peroxisomal proteins [7] that are compiled 
in Table 1. All peptides contained an extra N-terminal tyrosine residue to measure their concentration 
spectrophotometrically (ε274nm = 1405 M1·cm1), and are referred to as PTS1 nonapeptides along  
the manuscript. 
The PTS1 binding domain of human Pex5p (Pex5p-pbd; amino acids 235–602) and WT and LRM 
hAGT variants containing N-terminal hexa-histidine tags were expressed and purified as recently 
described [12]. Details on the protein constructs used can be found in the supplementary information. 
Mutations in the PTS1 sequence (Table 1) of AGT or AGT-LRM proteins were introduced by site-directed 
mutagenesis and the mutated sequences were confirmed by sequencing the entire AGT cDNA. Protein 
concentration was measured spectrophotometrically using  ε280nm = 50,880 M1·cm1 (Pex5p-pbd) or 
46,820 M1·cm1 (AGT proteins in monomer). 
3.2. Isothermal Titration Calorimetry 
Calorimetric measurements were carried out using a MicroCal ITC200 microcalorimeter (MicroCal, 
Malvern Instruments) with 205.9 μL cell volume. All the experiments were performed using using  
20 mM Na-HEPES (or Na-Phosphate), 200 mM NaCl, pH 7.4. AGT proteins (12–40 μM in protein 
subunit in the cell) were titrated using Pex5p-pbd (240–400 μM), while peptides (500 μM) were used to 
titrate Pex5p-pbd (20 μM in the cell). Each titration was initiated by a 0.5 μL injection followed by  
14–30 injections of 1.2–2.5 μL (spaced 150 s). Heats of dilution were determined experimentally from 
blank titrations. The association constants (Ka), binding enthalpy changes (ΔH), as well as the binding 
stoichiometries (N), were obtained by non-linear regression analysis using a one-independent-type-of-sites 
binding model implemented in the Origin 7.0. Software (Origin Lab Co., Northampton, MA, USA).  
The dissociation constant (Kd), binding Gibbs free energy (ΔG) and entropy (ΔS) changes were obtained 
from basic thermodynamic relationships (ΔG = ΔH  TΔS). ΔCp values were obtained from the linear 
dependence of ΔH on temperature in a 10–35 °C temperature range. 
3.3. Thermal Denaturation Studies 
Thermal denaturation of Pex5p-pbd was evaluated by measuring changes in the ellipticity at 222 nm 
in thermal scans (2 °C/min scan rate) in a 20–90 °C range. These experiments were performed in  
Na-Hepes 20 mM, 200 mM NaCl pH 7.4, using 5  μM Pex5p-pbd and 0–200  μM peptides, and carried 
out in a Jasco J-710 spectroscopolarimeter equipped with a Peltier element and using 1 mm pathlength 
cuvettes. Melting curves were normalized considering pre- and post-transition linear baselines, and  
the normalized curves presented as unfolded fraction of Pex5p-pbd vs. temperature. The Tm corresponds 
to the temperature at which the unfolded fraction is 0.5. 
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3.4. Proteolysis by Thermolysin 
Proteolysis experiments were performed using 10 nM thermolysin from Bacillus thermoproteolyticus 
rokko (Sigma-Aldrich, St. Louis, MO, USA), 20 μM Pex5p-pbd, in the absence or presence of the 
corresponding nonapeptides (10–500 μM). Proteolysis was performed at 25 °C in Na-Hepes 20 mM, 
200 mM NaCl, CaCl2 10 mM pH 7.4. Aliquots were withdrawn at different times and proteolysis 
quenched by the addition of EDTA (20 mM final concentration). Samples were analyzed by SDS-PAGE 
electrophoresis (12% PAGE), stained with Coomassie blue brilliant and gels were densitometered by 
ImageJ (http://rsbweb.nih.gov/ij/). 
3.5. Structural Modeling 
The crystal structure of the complex between AGT K390A mutant in complex with Pex5p-pbd  
(PDB code 4KYO; [6]) was used as a template to model different PTS1 sequences (compiled in Table 1). 
The three dimensional models were obtained with COOT [34]. Their geometry was optimized to minimize 
clashes while maintaining the correct stereochemistry of the model using COOT. A final automatic 
idealization cycle was preformed using Phenix [35]. Ribbon figures were produced using Pymol [36]. 
3.6. Structure-Energetic Calculations 
To calculate the theoretical values for ΔHint(25oC) and ΔCp using the structure, the  ΔASA for polar and 
apolar surfaces in the complex and for each protein individually (in Å2) were determined using a  
home-built software (kindly provided by Prof. Jose Manuel Sanchez-Ruiz, University of Granada, Spain), 
and following Equations (1) and (2) [20]: 
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3.7. Cell Cultures 
Chinese hamster ovary (CHO) cells (ATTC, Rockville, MD USA) were grown in alpha-minimal 
essential medium (-MEM, Lonza, Köln, Germany) supplemented with glutamine, penicillin/streptomycin 
and 5% fetal bovine serum. Cell transfections were performed using AGT cDNA variants (AGT-LRM 
or AGT-LRM-SKL) subcloned in pCIneo plasmids (Promega) with Transfast reagent (Promega, Madison, 
WI, USA), following manufacturer’s guidelines. After 24 h, cells were passed to plates containing  
13 mm glass coverslips for immunofluorescence studies. Mitochondria in half the coverslips were 
labeled by incubation with Mitotracker (CMXRos, Invitrogen, Carlsbad, CA, USA) at the end of the 
culture. Cells were fixed with 2% paraformaldehyde 72 h after transfection and immunofluorescence 
was performed as previously described [12]. Images were acquired with a laser scanning confocal 
microscope (Olympus Inverted IX81, Tokyo, Japan) using a 60× objective with immersion oil. 
For quantitative immune-colocalization, the system was optimized to detect two fluorescent signals 
in one specimen: one in the green channel detector for protein of interest AGT-LRM or AGT-LRM-SKL 
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and the other in the red channel, for either mitochondria labeled with mitotracker or peroxisomes  
labeled with peroxisomal membrane protein 70 (PMP70) antibody. When the two were seen to overlap 
(colocalization), it was assumed to be due to fluorescently labeled molecules binding to very close or 
indeed identical spatial positions. Colocalization events (or the lack thereof) were analyzed quantitatively 
with FluoView software (Olympus, Tokyo, Japan) and ImageJ software (NIH, Bethesda, MD, USA) 
with the JACoP plugin, based on a global statistic approach that conducts an intensity correlation 
coefficient-based examination [32,37]. The Fisher transformation was applied to data obtained from 
ImageJ as well when calculating the mean values of colocalization coefficients and constructing the 
respective 95% confidence intervals. Descriptive statistical analysis of colocalization parameters 
(Pearson’s coefficient, Manders’ overlap coefficient and split Manders’ coefficients) was performed. 
4. Conclusions 
In this work, we have explored several aspects of the molecular recognition of cargo proteins by 
Pex5p not well investigated previously. By comparing the energetics underlying Pex5p binding to 
different PTS1 peptides and their counterparts in the full-length AGT cargo protein, we have provided 
structural and energetic insight into the contribution from different regions of the cargo protein to the 
binding affinity for Pex5p. Moreover, binding of cargo proteins lead to stabilization of the peroxisomal 
receptor, which may be exploited to modulate the intracellular fate of PTS1 cargo proteins. We also 
demonstrate this experimentally, in cultured cells, showing that mistargeting of the most common PH1 
mutation can be corrected by rational modulation of its binding affinity for Pex5p, which may be a useful 
tool to find new therapeutic agents to treat PH1. 
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